| 1405-89-6 |
Zinc Bacitracin |
Bacitracin zinc salt; Bacitracin Zinc; L-isoleucinamide, N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-alpha-glutamyl-N-[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-15-(1-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-12-(phenylmethyl)-1,4,7,10,13,16,19-heptaazacyclopentacos-21-yl]-, zinc salt (1:1); zinc N-{[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazol-4-yl]carbonyl}-L-leucyl-5-oxidanidyl-5-oxidanylidene-D-norvalyl-N-{(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxylatomethyl)-9-(1H-imidazol-5-ylmethyl)-15-[(1S)-1-methylpropyl]-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl}-L-isoleucinamide |
C66H101N17O16SZn |
19
supplier(s)
1405-89-6 |
| 144701-48-4 |
Telmisartan |
4'[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 2-[4-[[4-methyl-6-(1-methylbenzoimidazol-2-yl)-2-propyl-benzoimidazol-1-yl]methyl]phenyl]benzoic acid; [1,1'-Biphenyl]-2-carboxylicacid,4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; tert-butyl 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylate |
C37H38N4O2 |
26
supplier(s)
144701-48-4 |
| 100-01-6 |
4-Nitroaniline |
C.I. 37035; C.I. Azoic Diazo Component 37; C.I. Developer 17; 4-Nitroaniline; p-Nitroaniline; fast red GG base; Para Nitro Aniline; Paranitroaniline; Azoic Diazo Component 37; 1-Amino-4-nitrobenzene; 4-nitroaniline hydrochloride (1:1); mercury bis[(4-nitrophenyl)azanide] |
C6H6N2O2 |
3
supplier(s)
100-01-6 |
| 104987-11-3 |
Tacrolimus |
Tacarolimus; 3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,; (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone; (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-prop-2-en-1-yl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
C44H69NO12 |
24
supplier(s)
104987-11-3 |
| 14636-12-5 |
Terlipressin |
n-(n-(n-glycylglycyl)glycyl)-8-l-lysinevasopressin; (2s)-1-[(4s,7s,10s,13s,16s,19s)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(1s)-5-amino-1-(carbamoylmethylcarbamoyl)pentyl]pyrrolidine-2-carboxamide; (2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-N-{(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide (non-preferred name) |
C52H74N16O15S2 |
38
supplier(s)
14636-12-5 |
| 153-18-4 |
Rutin |
C.I. 75730; Rutin [JAN]; (+)-Rutin Hydrate; Quercetin-3-rutinoside~Vitamin P; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-D-glucopyranoside |
C27H30O16 |
37
supplier(s)
153-18-4 |
| 100-06-1 |
4'-Methoxyacetophenone |
p-Acetanisole; p-Acetylanisole; 4-Methoxyacetophenone; 4-Methoxy Acetophenone; 1-(4-methoxyphenyl)ethanone |
C9H10O2 |
3
supplier(s)
100-06-1 |
| 120511-73-1 |
Anastrozole |
ICI-D-1033;ARIMIDEX;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;ANASTROZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha’,alpha’-tetramethyl-5-(1h-1,2,4-t |
C17H19N5 |
19
supplier(s)
120511-73-1 |
| 1115-70-4 |
1,1-Dimethylbiguanide hydrochloride |
1,1-dimethyl-biguanidhydrochloride;diabefagos;diformin;dimethylbiguanidehydrochloride;Dimethyldiguanidinehydrochloride;gliformin;haurymellin;meguan |
C4H12ClN5 |
14
supplier(s)
1115-70-4 |
| 183321-74-6 |
Erlotinib |
4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-; ERLOTININ; Erlotinib & its intermediates (Developing); Erlotinib Base |
C22H23N3O4 |
9
supplier(s)
183321-74-6 |
Pharma Sources Insight July 2025
